COMMUNIQUÉS West-GlobeNewswire

Matinas BioPharma to Present at the 20th ICHS Symposium on Infections in the Immunocompromised Host
12/06/2018
BEDMINSTER, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Matinas BioPharma Holdings, Inc. (NYSE AMER:MTNB), a clinical-stage biopharmaceutical company focused on enabling the delivery of life-changing medicines using its [...]
Opiant Pharmaceuticals Appoints Biotech and Pharmaceutical Industry Veteran Richard Daly to Board of Directors
12/06/2018
SANTA MONICA, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals, Inc. ("Opiant") (NASDAQ:OPNT), a specialty pharmaceutical company developing pharmacological treatments for addictions, today announced the [...]
Cancer Genetics Strengthens Management Team with Appointment of Michael McCartney as Chief Commercial Officer
12/06/2018
Executive appointment underscores continued execution of new corporate strategy of expanding Biopharma and Discovery businesses RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX), a [...]
Lotus Purchases 23-Acre Cannabis Facility Site in Armstrong BC
12/06/2018
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, June 12, 2018 (GLOBE NEWSWIRE) -- Lotus Ventures Inc. (CSE:J) has exercised the option to purchase [...]
Precipio Reminds Shareholders to Vote Before the Annual General Meeting on June 15, 2018
12/06/2018
NEW HAVEN, Conn., June 12, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ:PRPO), today reminded its shareholders to vote on proposals 1-6 in accordance with the recommendations of the [...]
OncoMed Doses First Patient in Phase 1b Portion of anti-TIGIT Clinical Trial
12/06/2018
Expanded Phase of Trial will Assess anti-TIGIT in Combination with anti-PD1 REDWOOD CITY, Calif., June 12, 2018 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals Inc. (NASDAQ:OMED), a clinical-stage biopharmaceutical company [...]
Bellerophon Therapeutics to Participate on Panel at JMP Securities Life Sciences Conference
12/06/2018
WARREN, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq:BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company, today announced that it will participate on a [...]
Tyme Releases Detailed Data and Analyses with SM-88 From the First Human Study and Compassionate Use Programs
12/06/2018
NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ:TYME), a clinical-stage biotechnology company developing cancer therapeutics, today release detailed patient data and analyses from both the [...]
Akcea and Ambry Genetics to Launch hATTR Compass, a Genetic Testing Program for People with Suspected Hereditary ATTR Amyloidosis
12/06/2018
hATTR Compass to provide no-cost, confidential genetic testing and genetic counseling services, potentially enabling faster diagnosis CAMBRIDGE, Mass., June 12, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq: [...]
Online Sales Climb to $669,000 in May, Driving May Revenues 639% Above 2017 for PotNetwork Holdings, Inc.'s Diamond CBD
12/06/2018
With Over a $100,000 in Orders in The Final 5 Days of May,Year Over Year Gains Continue To Build Momentum FT LAUDERDALE, Fla., June 12, 2018 (GLOBE NEWSWIRE) -- Via OTC PR Wire -- PotNetwork Holdings, Inc. (OTC Pink: [...]
Moleculin Targets accelerated FDA approval of WP1732; Pursues Development for Ocular Tumors
12/06/2018
HOUSTON, June 12, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc. (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
Idera Pharmaceuticals Reports Results from Phase 2 Trial of IMO-8400 in Dermatomyositis
12/06/2018
Clinical trial did not meet primary endpoint of statistically significant reduction of CDASI for IMO-8400 versus placebo EXTON, Pa., June 12, 2018 (GLOBE NEWSWIRE) -- Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), a [...]
Avalon GloboCare Forms Joint Venture with Jiangsu Unicorn to Establish Provincial Network of Translational Cellular Therapy and Bio-Banking Programs
12/06/2018
FREEHOLD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has formed a joint venture with Jiangsu [...]
Restoration Robotics Launches New Continuing Education Master Class Series for the ARTAS® Robotic Hair Restoration System
12/06/2018
First class in new continuing education series led by prominent aesthetic surgeon, Robert M. Bernstein, MD in New York, NY Additional Master Classes in the series to be led by experienced faculty SAN JOSE, Calif., June [...]
Phase 3 data in the online Journal of the American Academy of Dermatology show Aclaris' ESKATA™ is safe and effective in treating persons with raised seborrheic keratoses
12/06/2018
WAYNE, Pa., June 12, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to [...]
CureVac Announces Appointment of Matthew L. S. Beck as Vice President of Investor Relations
12/06/2018
TÜBINGEN, Germany and BOSTON, June 12, 2018 (GLOBE NEWSWIRE) -- CureVac AG, a fully-integrated biopharmaceutical company pioneering the field of mRNA-based drugs, today announced the appointment of Matthew L. S. Beck as [...]
Surface Oncology Announces Initiation of Phase I Clinical Trial of SRF373 / NZV930
12/06/2018
CAMBRIDGE, Mass., June 12, 2018 (GLOBE NEWSWIRE) -- Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, today [...]
Chimerix Announces Discovery and Demonstrated Preclinical Activity Supporting Ongoing Phase 1 Study of New Antiviral for Treatment and Prevention of Norovirus
12/06/2018
- CMX521 is Active In Vitro Against All Strains of Norovirus Tested - - Oral Dosing of CMX521 Inhibited Norovirus Replication in Animal Model - DURHAM, N.C., June 12, 2018 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), a [...]
ProQR Receives up to $5 Million in Partnership with EB Research Partnership and EB Medical Research Foundation to Develop QR-313 for the Treatment of Dystrophic Epidermolysis Bullosa
12/06/2018
The funding will be used for the clinical development of QR-313 Clinical trial in DEB patients to start in the second quarter of 2018 LEIDEN, the Netherlands, June 12, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. ( [...]

Pages